Prev Close | 47.14 |
Open | 46.63 |
Day Low/High | 45.32 / 46.67 |
52 Wk Low/High | 39.40 / 62.70 |
Volume | 223.82K |
Prev Close | 47.14 |
Open | 46.63 |
Day Low/High | 45.32 / 46.67 |
52 Wk Low/High | 39.40 / 62.70 |
Volume | 223.82K |
Exchange | NYSE |
Shares Outstanding | 50.21B |
Market Cap | 2.28B |
P/E Ratio | 19.67 |
Div & Yield | N.A. (N.A) |
I am expecting Jerome Powell to be just a touch more hawkish.
As the trading day winds down, there is only one company reporting after the close -- health and wellness product name Landec Corp. . Consensus expectations are for EPS of $0.00 vs. $0.08 in the year-ago quarter. We recently added shares of GNC Hold...
Stand-alone vitamin and supplement shops like GNC and Vitamin Shoppe shares will continue to fall in light of a Justice Department investigation.
At what price should shares of these companies be bought or sold?
These companies should feast as more obese Americans turn to exercise and healthy foods.
The yields are still being pushed higher.
Did my portfolio pass muster?
Though broad futures have improved somewhat. Market futures are still pointing to a down open, but they have improved somewhat since my first Diary post this morning. Meantime, oil just can't get any love. The International Energy Agency (IEA) has c...
The trend is global, and the investment opportunities extend beyond health-care companies.
When will real short-selling come back into vogue?
Still plenty of earnings, but the econ calendar lightens up.
Winter weather grounds shipper's results; futures on the rise.
The start of diet season - January through April - looks bright for Medifast so far, says the company's CEO Michael MacDonald, as does Medifast's expansion plans into Canada.
Let's run through them.
As new research raises skepticism about supplements, you may want to take profits.
Keep it light until a more compelling set-up presents itself.
Given recent volatility, a cautious approach is best.
Should you wish to bet against the much-maligned hedge fund manager, here's a handy buy-and-sell list.
Deutsche Bank is pressing the issue. Break in: Nu Skin Enterprises (NUS) and Avon Products (AVP) are being pushed by Deustche Bank now.